NDAORALTABLET, EXTENDED RELEASE
Approved
May 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PROQUIN XR (ciprofloxacin hydrochloride) by Novartis is clinical pharmacology absorption when proquin xr is administered with food, approximately 87% of ciprofloxacin is gradually released from the tablet over a 6-hour period. First approved in 2005.
Drug data last refreshed 2d ago
Mechanism of Action
CLINICAL PHARMACOLOGY Absorption When Proquin XR is administered with food, approximately 87% of ciprofloxacin is gradually released from the tablet over a 6-hour period. When administered following a meal maximum plasma ciprofloxacin concentrations are attained approximately 4.5-7 hours after…
Worked on PROQUIN XR at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.